PROCF (Sofgen Pharma) Accumulated Depreciation: $-67.2 Mil (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PROCF Sofgen Pharma SA PROCF
24 GF Score
Price $0.00
View Full Analysis

What is Sofgen Pharma Accumulated Depreciation?

Sofgen Pharma PROCF 24 Accumulated Depreciation is $-67.2 Mil as of Dec. 2024. GuruFocus rates PROCF with a GF Score™ of 24/100.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Sofgen Pharma's quarterly accumulated depreciation increased from Sep. 2023 ($-58.0 Mil) to Dec. 2023 ($-70.3 Mil) but then stayed the same from Dec. 2023 ($-70.3 Mil) to Dec. 2024 ($-67.2 Mil).

Sofgen Pharma's annual accumulated depreciation increased from Dec. 2022 ($-47.9 Mil) to Dec. 2023 ($-70.3 Mil) but then stayed the same from Dec. 2023 ($-70.3 Mil) to Dec. 2024 ($-67.2 Mil).

Sofgen Pharma Accumulated Depreciation Related Terms

Sofgen Pharma Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Sofgen Pharma's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sofgen Pharma Accumulated Depreciation Chart

Sofgen Pharma Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accumulated Depreciation
Get a 7-Day Free Trial -44.96 -44.02 -47.93 -70.31 -67.17

Sofgen Pharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Dec24
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -55.46 -58.01 -70.31 -67.17
PROCF
24GF Score
Sofgen Pharma SA PROCF
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sofgen Pharma Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $-67.2 Mil mean?
Sofgen Pharma (PROCF) has a Accumulated Depreciation of $-67.2 Mil as of Dec. 2024. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Sofgen Pharma and its competitors.
Is Sofgen Pharma's Accumulated Depreciation too high?
Sofgen Pharma's current Accumulated Depreciation is $-67.2 Mil. Overall, Sofgen Pharma has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Sofgen Pharma's Accumulated Depreciation compare to BKUH and ORGO?
Sofgen Pharma's Accumulated Depreciation of $-67.2 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Drug Manufacturers company?
A good Accumulated Depreciation depends on the Drug Manufacturers industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Sofgen Pharma and its competitors. Sofgen Pharma's current Accumulated Depreciation is $-67.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sofgen Pharma stock overvalued right now?
Sofgen Pharma (PROCF) has a current Accumulated Depreciation of $-67.2 Mil. The current Accumulated Depreciation is $-67.2 Mil. Sofgen Pharma's overall GF Score™ is 24/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Sofgen Pharma (PROCF), the current Accumulated Depreciation is $-67.2 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sofgen Pharma Business Description

Address 9 Rue de Bitbourg, Luxembourg, LUX, L-1273
Procaps Group SA is an integrated healthcare and pharmaceutical company that develops and manufactures pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. The company's segment includes NextGel, Procaps Colombia, CAN, CASAND, and Diabetrics. It generates maximum revenue from the NextGel segment. It has geographic presence in Bolivia, Brazil, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Nicaragua, Panama, Peru, and the United States.
24GF Score

Get the complete analysis for PROCF

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price